| 标题 |
 Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib |
| 网址 | |
| DOI | |
| 其它 |
期刊：Annals of oncology : official journal of the European Society for Medical Oncology 作者：Horinouchi H; Cho BC; Camidge DR; Goto K; Tomasini P; et al 出版日期：2025/05/01 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
DW
hkk
Zilaap
aaaa
伯克利芙蓉王
123
Criminology34
吃葡萄不吐葡萄皮
123
高贵千琴
贪玩的秋柔
null
坚强冰枫
152455
OK
舒适的如萱
Nole
彭于彦祖
疯狂加载ing
皖公网安备34019202002308
